These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36689556)

  • 1. PANACEA: network-based methods for pharmacotherapy prioritization in personalized oncology.
    Ulgen E; Ozisik O; Sezerman OU
    Bioinformatics; 2023 Jan; 39(1):. PubMed ID: 36689556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PRODIGY: personalized prioritization of driver genes.
    Dinstag G; Shamir R
    Bioinformatics; 2020 Mar; 36(6):1831-1839. PubMed ID: 31681944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PersonaDrive: a method for the identification and prioritization of personalized cancer drivers.
    Erten C; Houdjedj A; Kazan H; Taleb Bahmed AA
    Bioinformatics; 2022 Jun; 38(13):3407-3414. PubMed ID: 35579340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PanDrugs: a novel method to prioritize anticancer drug treatments according to individual genomic data.
    Piñeiro-Yáñez E; Reboiro-Jato M; Gómez-López G; Perales-Patón J; Troulé K; Rodríguez JM; Tejero H; Shimamura T; López-Casas PP; Carretero J; Valencia A; Hidalgo M; Glez-Peña D; Al-Shahrour F
    Genome Med; 2018 May; 10(1):41. PubMed ID: 29848362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prioritization of cancer driver gene with prize-collecting steiner tree by introducing an edge weighted strategy in the personalized gene interaction network.
    Zhang SW; Wang ZN; Li Y; Guo WF
    BMC Bioinformatics; 2022 Aug; 23(1):341. PubMed ID: 35974311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting cancer drug response using parallel heterogeneous graph convolutional networks with neighborhood interactions.
    Peng W; Liu H; Dai W; Yu N; Wang J
    Bioinformatics; 2022 Sep; 38(19):4546-4553. PubMed ID: 35997568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical drug response prediction from preclinical cancer cell lines by logistic matrix factorization approach.
    Emdadi A; Eslahchi C
    J Bioinform Comput Biol; 2022 Apr; 20(2):2150035. PubMed ID: 34923927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prioritizing disease genes with an improved dual label propagation framework.
    Zhang Y; Liu J; Liu X; Fan X; Hong Y; Wang Y; Huang Y; Xie M
    BMC Bioinformatics; 2018 Feb; 19(1):47. PubMed ID: 29422030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovering personalized driver mutation profiles of single samples in cancer by network control strategy.
    Guo WF; Zhang SW; Liu LL; Liu F; Shi QQ; Zhang L; Tang Y; Zeng T; Chen L
    Bioinformatics; 2018 Jun; 34(11):1893-1903. PubMed ID: 29329368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting human microbe-drug associations via graph convolutional network with conditional random field.
    Long Y; Wu M; Kwoh CK; Luo J; Li X
    Bioinformatics; 2020 Dec; 36(19):4918-4927. PubMed ID: 32597948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel network control model for identifying personalized driver genes in cancer.
    Guo WF; Zhang SW; Zeng T; Li Y; Gao J; Chen L
    PLoS Comput Biol; 2019 Nov; 15(11):e1007520. PubMed ID: 31765387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting anti-cancer drug response by finding optimal subset of drugs.
    Yassaee Meybodi F; Eslahchi C
    Bioinformatics; 2021 Dec; 37(23):4509-4516. PubMed ID: 34170297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data.
    Fernández-Navarro P; López-Nieva P; Piñeiro-Yañez E; Carreño-Tarragona G; Martinez-López J; Sánchez Pérez R; Aroca Á; Al-Shahrour F; Cobos-Fernández MÁ; Fernández-Piqueras J
    BMC Cancer; 2019 Oct; 19(1):1005. PubMed ID: 31655559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling gene-wise dependencies improves the identification of drug response biomarkers in cancer studies.
    Nikolova O; Moser R; Kemp C; Gönen M; Margolin AA
    Bioinformatics; 2017 May; 33(9):1362-1369. PubMed ID: 28082455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Random walk with restart on multiplex and heterogeneous biological networks.
    Valdeolivas A; Tichit L; Navarro C; Perrin S; Odelin G; Levy N; Cau P; Remy E; Baudot A
    Bioinformatics; 2019 Feb; 35(3):497-505. PubMed ID: 30020411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. driveR: a novel method for prioritizing cancer driver genes using somatic genomics data.
    Ülgen E; Sezerman OU
    BMC Bioinformatics; 2021 May; 22(1):263. PubMed ID: 34030627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HyDRA: gene prioritization via hybrid distance-score rank aggregation.
    Kim M; Farnoud F; Milenkovic O
    Bioinformatics; 2015 Apr; 31(7):1034-43. PubMed ID: 25411330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MERIDA: a novel Boolean logic-based integer linear program for personalized cancer therapy.
    Lenhof K; Gerstner N; Kehl T; Eckhart L; Schneider L; Lenhof HP
    Bioinformatics; 2021 Nov; 37(21):3881-3888. PubMed ID: 34352075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An extensive analysis of disease-gene associations using network integration and fast kernel-based gene prioritization methods.
    Valentini G; Paccanaro A; Caniza H; Romero AE; Re M
    Artif Intell Med; 2014 Jun; 61(2):63-78. PubMed ID: 24726035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.